Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study

Am J Hematol. 2018 Aug;93(4):E84-E86. doi: 10.1002/ajh.25014. Epub 2018 Jan 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Distribution
  • Aged
  • Calreticulin / genetics*
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Gene Frequency
  • Humans
  • Janus Kinase 2 / genetics*
  • Kaplan-Meier Estimate
  • Leukemia, Myeloid, Acute / epidemiology
  • Male
  • Middle Aged
  • Mutation*
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / mortality
  • Myeloproliferative Disorders / physiopathology
  • Phenotype
  • Prognosis
  • Proportional Hazards Models
  • Receptors, Thrombopoietin / genetics*
  • Sex Distribution
  • Statistics, Nonparametric
  • Thrombosis / epidemiology
  • Thrombosis / etiology

Substances

  • CALR protein, human
  • Calreticulin
  • Receptors, Thrombopoietin
  • MPL protein, human
  • JAK2 protein, human
  • Janus Kinase 2